- Home
- MNOV vs INTT Comparison
MNOV vs INTT Comparison
Compare MNOV & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MNOV | INTT |
|---|---|---|
| Founded | 2000 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.7M | 175.3M |
| IPO Year | 2004 | 1997 |
Fundamental Metrics
Financial Performance| Metric | MNOV | INTT |
|---|---|---|
| Price | $1.38 | $14.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $7.50 | ★ $13.50 |
| AVG Volume (30 Days) | 63.8K | ★ 164.9K |
| Earning Date | 05-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,360,807.00 | ★ $66,801,000.00 |
| Revenue This Year | N/A | $13.07 |
| Revenue Next Year | N/A | $6.52 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 194.15 | 66.06 |
| 52 Week Low | $1.13 | $5.24 |
| 52 Week High | $1.96 | $15.66 |
Technical Indicators
Market Signals| Indicator | MNOV | INTT |
|---|---|---|
| Relative Strength Index (RSI) | 44.39 | 58.22 |
| Support Level | $1.22 | $7.21 |
| Resistance Level | $1.40 | $15.01 |
| Average True Range (ATR) | 0.06 | 0.88 |
| MACD | 0.01 | -0.14 |
| Stochastic Oscillator | 17.64 | 23.58 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.
About INTT inTest Corporation
inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.